Characteristics of Patients With Amyloidosis & Heart Failure Being Evaluated for a Heart Transplant
NCT00456040 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2007-04-04
Summary
The purpose of this study is to describe the characteristics of patients with amyloidosis and severe heart failure being evaluated for cardiac and stem cell transplantation.
Conditions
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Marc J Semigran, MD · Massachusetts General Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-03-31
- Completion
- 2007-03-31
More Related Trials
-
Cardiac Amyloidosis in Patients With Aortic Stenosis
NCT07170306 ·Status: NOT_YET_RECRUITING
-
PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY
NCT05098665 ·Status: RECRUITING ·Phase: NA
-
The Role of Myocardial Fibrosis in Degenerative Mitral Regurgitation
NCT02355418 ·Status: COMPLETED
-
Cardiac Contractility Modulation Therapy in Amyloid Cardiomyopathy Patients With Heart Failure
NCT05167799 ·Status: UNKNOWN
-
Aortic Stenosis and Cardiac Amyloidosis
NCT06129331 ·Status: RECRUITING
-
Amyloidosis Incidence in High-Risk Cardiac Device Patients
NCT06186167 ·Status: RECRUITING
-
Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis
NCT02798705 ·Status: RECRUITING
-
The Effectiveness of Surgical Treatment of Patients With Ischemic Cardiomyopathy
NCT04489355 ·Status: COMPLETED
-
Cardiac Amyloidosis Prevalence and Outcome in Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Implantation
NCT05384418 ·Status: COMPLETED ·Phase: NA
-
Impact of Amyloidosis on TAVI Patients
NCT03984877 ·Status: UNKNOWN
-
Prevalence and Significance of ATTR Aortic Valve Amyloidosis in Degenerative Aortic Stenosis
NCT04636684 ·Status: RECRUITING ·Phase: NA
-
Fate of Moderate Secondary Mitral Regurgitation in Patients Undergoing Aortic Valve Surgery for Severe Aortic Regurgitation
NCT05774808 ·Status: COMPLETED
-
Prevalence of Wildtype Amyloid After TAVR
NCT03825406 ·Status: WITHDRAWN
-
Prospective Study Looking at Quality of Life Measures in Non-ischaemic Cardiomyopathy After Mitral Valve Repair
NCT00483236 ·Status: WITHDRAWN
-
Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy
NCT06352307 ·Status: RECRUITING
-
Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
NCT05648825 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure
NCT06866600 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia
NCT06338839 ·Status: TERMINATED
-
Structural Heart and Valve Network PROSPECTIVE Registry
NCT03928639 ·Status: WITHDRAWN
-
Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
NCT00224809 ·Status: COMPLETED ·Phase: NA
-
Surgical Planning for Reconstruction of Complex Heart Defects
NCT00972608 ·Status: COMPLETED
-
Atrial Amyloid May Influence Outcomes in Patients Undergoing Surgical Aortic Valve Replacement
NCT07105501 ·Status: COMPLETED
-
Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.
NCT02260466 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
In-depth Characterization of Atriogenic Secondary Tricuspid Regurgitation Due to Atrial Fibrillation
NCT05749107 ·Status: RECRUITING
-
Optimizing Strategy of Coronary Revascularization in Patients With Multivessel Lesions Combined Heart Failure
NCT02775578 ·Status: UNKNOWN ·Phase: NA